Molbio Diagnostics hosts Q1FY27 earnings call on Sep 8
- Molbio Diagnostics schedules earnings call for Sep 8, 2026, at 4:00 pm IST
- Discussion focuses on Q1FY27 results for the quarter ended June 30, 2026
- CEO Sriram Natarajan and CFO Manan Bimal Khokhani among key participants
- Disclosure made under SEBI LODR Regulation 30

*this image is generated using AI for illustrative purposes only.
Molbio Diagnostics Limited has scheduled an earnings conference call for Tuesday, September 8, 2026, at 4:00 pm IST. The session will discuss the company’s financial performance for the quarter ended June 30, 2026.
The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The invitation is available on the company’s website.
Management Participants
The following executives will participate in the conference call:
- Sriram Natarajan, Executive Director & Chief Executive Officer
- Dr Chandrasekhar Nair, Executive Director & Chief Technology Officer
- Shiva Sriram, President – Business Development
- Manan Bimal Khokhani, President, Finance and Accounts & CFO
- Indraneil Borkakoty, President – Corporate Strategy, Mergers & Acquisitions and Investor Relations
Participants are requested to dial in five minutes in advance. The event will be hosted via Zoom.
Historical Stock Returns for Molbio Diagnostics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.17% | -9.74% | 0.0% | 0.0% | 0.0% | 0.0% |
How will Molbio Diagnostics' Q2 FY27 revenue growth trajectory compare against the broader Indian diagnostics sector amid current regulatory shifts?
What specific M&A targets or strategic partnerships might Indraneil Borkakoty highlight given his role in Corporate Strategy and the company's expansion goals?
Will Dr. Chandrasekhar Nair outline any breakthroughs in rapid diagnostic technologies that could provide a competitive moat against global players?

























